Xiaofeng Yan

2.5k total citations
54 papers, 1.2k citations indexed

About

Xiaofeng Yan is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Xiaofeng Yan has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in Xiaofeng Yan's work include Pharmacological Effects of Natural Compounds (6 papers), Antifungal resistance and susceptibility (6 papers) and Fungal Infections and Studies (5 papers). Xiaofeng Yan is often cited by papers focused on Pharmacological Effects of Natural Compounds (6 papers), Antifungal resistance and susceptibility (6 papers) and Fungal Infections and Studies (5 papers). Xiaofeng Yan collaborates with scholars based in China and United States. Xiaofeng Yan's co-authors include Qiang-min Xie, Xinwei Dong, Huimin Xu, Ximei Wu, Haibin Dai, Yicheng Xie, Yangmin Hu, Yong-liang Jia, Huijuan Shen and Fenfen Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Xiaofeng Yan

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Yan China 21 356 219 184 152 148 54 1.2k
Halmurat Upur China 22 516 1.4× 174 0.8× 167 0.9× 167 1.1× 158 1.1× 86 1.4k
Iraj Khodadadi Iran 26 523 1.5× 217 1.0× 90 0.5× 200 1.3× 106 0.7× 130 2.0k
Shenghao Tu China 20 514 1.4× 192 0.9× 327 1.8× 219 1.4× 168 1.1× 70 1.7k
Sean P. Troth United States 13 288 0.8× 111 0.5× 169 0.9× 81 0.5× 93 0.6× 28 1.3k
Peng Cao China 17 301 0.8× 213 1.0× 204 1.1× 134 0.9× 67 0.5× 31 1.1k
DR Mould United States 7 240 0.7× 158 0.7× 117 0.6× 177 1.2× 124 0.8× 7 1.5k
Jeremiah D. Momper United States 22 290 0.8× 130 0.6× 181 1.0× 141 0.9× 111 0.8× 86 1.4k
Peiyong Zheng China 21 486 1.4× 433 2.0× 93 0.5× 124 0.8× 62 0.4× 81 1.2k
So Young Park South Korea 21 277 0.8× 217 1.0× 69 0.4× 111 0.7× 231 1.6× 63 1.1k

Countries citing papers authored by Xiaofeng Yan

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Yan more than expected).

Fields of papers citing papers by Xiaofeng Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Yan. The network helps show where Xiaofeng Yan may publish in the future.

Co-authorship network of co-authors of Xiaofeng Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Yan. A scholar is included among the top collaborators of Xiaofeng Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Yan. Xiaofeng Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Xiaofeng, et al.. (2025). Quantitative and visualization study on pressure resistance of magnetic fluid seals. Smart Materials and Structures. 34(12). 125010–125010. 1 indexed citations
2.
3.
Cheng, Mingxi, Songli Wang, Xiaofeng Yan, et al.. (2021). A COVID-19 Rumor Dataset. Frontiers in Psychology. 12. 644801–644801. 47 indexed citations
4.
Yan, Xiaofeng, et al.. (2020). Tuberculosis Infection Control Project Management Experience and Its Application in COVID-19 Response. China CDC Weekly. 2(34). 666–668. 2 indexed citations
5.
6.
7.
Gao, Jingtao, Xiaofeng Yan, Tongxin Li, et al.. (2020). Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients. International Journal of Infectious Diseases. 100. 196–198. 3 indexed citations
8.
9.
10.
Wen, Hao, et al.. (2019). <p>Total extract of Xin Jia Xuan Bai Cheng Qi decoction inhibits pulmonary fibrosis via the TGF-β/Smad signaling pathways in vivo and in vitro</p>. Drug Design Development and Therapy. Volume 13. 2873–2886. 19 indexed citations
11.
Gao, Wengui, et al.. (2019). Effect of composition of Cu-ZnO-CeO 2 catalyst on its performance for methanol synthesis from CO 2 hydrogenation. Ranliao huaxue xuebao. 47(5). 523–531. 1 indexed citations
12.
Lu, Ming, et al.. (2019). CTGF Triggers Rat Astrocyte Activation and Astrocyte-Mediated Inflammatory Response in Culture Conditions. Inflammation. 42(5). 1693–1704. 17 indexed citations
13.
Jiang, Junxia, Shui-juan Zhang, Huijuan Shen, et al.. (2017). Rac1 signaling regulates cigarette smoke-induced inflammation in the lung via the Erk1/2 MAPK and STAT3 pathways. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(7). 1778–1788. 27 indexed citations
14.
Yan, Xiaofeng, et al.. (2017). Salvianolic acid B protects hepatocytes from H2O2injury by stabilizing the lysosomal membrane. World Journal of Gastroenterology. 23(29). 5333–5333. 17 indexed citations
15.
Lü, Ming, et al.. (2015). Predictive value of serum caspase-cleaved cytokeratin-18 concentrations after acute intracerebral hemorrhage. Clinica Chimica Acta. 452. 124–128. 15 indexed citations
16.
Xu, Huimin, Haibin Dai, Xiaofeng Yan, et al.. (2014). Use of evidence-based pharmacotherapy for secondary prevention of coronary heart disease: A Chinese medicine hospital versus a general hospital. Chinese Journal of Integrative Medicine. 20(5). 375–380. 3 indexed citations
17.
18.
Zhang, Linhui, Yong-liang Jia, Xixi Lin, et al.. (2013). AD-1, a novel ginsenoside derivative, shows anti-lung cancer activity via activation of p38 MAPK pathway and generation of reactive oxygen species. Biochimica et Biophysica Acta (BBA) - General Subjects. 1830(8). 4148–4159. 55 indexed citations
19.
Dai, Haibin, et al.. (2013). Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials. BMC Health Services Research. 13(1). 461–461. 37 indexed citations
20.
Xie, Yicheng, Xinwei Dong, Ximei Wu, Xiaofeng Yan, & Qiang-min Xie. (2008). Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide-induced acute pulmonary inflammation in mice. International Immunopharmacology. 9(2). 194–200. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Halmurat Upur Breakdown of academic impact, for papers by Iraj Khodadadi Breakdown of academic impact, for papers by Shenghao Tu Breakdown of academic impact, for papers by Sean P. Troth Breakdown of academic impact, for papers by Peng Cao Breakdown of academic impact, for papers by DR Mould Breakdown of academic impact, for papers by Jeremiah D. Momper Breakdown of academic impact, for papers by Peiyong Zheng Breakdown of academic impact, for papers by So Young Park
Rankless by CCL
2026